Company News

Lucerne, Switzerland – October 1st, 2024 – Chairman Nakao and the GC Holding Board of Directors announce the appointment of Dr. Per Falk as CEO effective October 1, 2024.

Dental academics and clinicians are invited to apply for Foundation Nakao Grant from 2 September 2024. This is the sixth round of funding made available by the prestigious foundation since its launch in 2018. The organization supports clinical trials and research in important topics such as minimum intervention dentistry and oral health of the elderly.

Dental academics and clinicians are invited to apply for Foundation Nakao Grant from 4 September 2023. This is the fifth round of funding made available by the prestigious foundation since its launch in 2018. The organization supports clinical trials and research in important topics such as minimum intervention dentistry and oral health of the elderly.

The GC Group has donated products as emergency support for the Turkey-Syria earthquake that occurred on February 6, 2023.

GC Corporation would like to announce that it has agreed with Olympus Terumo Biomaterials Corporation (hereinafter referred to as "OTB") to succeed those businesses of the development, manufacturing and sales of such biomaterials as TERUPLUG™ (protective material for extraction wounds primarily for dentistry), TERUDERMIS™ (graft for dermal defects primarily for plastic surgery and emergency medical treatment), etc. as well as the dental product sales business which OTB handles in the collagen business etc. through an absorption-type company split with the aim of further enhancement of the businesses of OTB and GC.

GC Corporation (Bunkyo, Tokyo) is proud to announce that President and CEO, Dr. Kiyotaka Nakao, was awarded the title of “Officer in the Order of the Crown” by the Kingdom of Belgium. This award was bestowed in recognition of his longstanding efforts to promote bilateral relations between Japan and Belgium, primarily through the investment sector.

The 11th Quality Management Level Research 2022 – Awarding Ceremony and Memorial Lecture were held.

The result of the 11th Quality Management Level Research in 2022 conducted by the Union of Japanese Scientists and Engineers (JUSE) and sponsored by Nikkei Inc. was announced in December 2022. We are quite pleased that GC CORPORATION was awarded the highest ranking - 5 stars. Until the last time the result was announced in rank order and GC was ranked 2nd in 2018. From 2022 it was changed to rating and 5 stars were given to 4 companies; GC, Suntory Holdings Limited., Ricoh Company, Ltd. and CARECOM CO., LTD. Our group company GC DENTAL PRODUCTS CORP. was also rated 3 stars.

GC America is excited to announce the appointment of Joe Talanges as the new President and Chief Operating Officer of GC America as of December 12, 2022, bringing his 30 years of med-tech and biopharma industry knowledge across multiple countries and continents to his new role. As President and COO of GC America, Talanges will be responsible for leading all operating, development and commercial functions and accelerating growth across the region and focus on key markets in The Americas including the United States, Canada, Mexico, and Brazil.

On October 5, the Union of Japanese Scientists and Engineers (JUSE) announced the 2021 recipient of the "Deming Prize," awarded to companies and individuals who have achieved excellent results in study of Total Quality Management (TQM). Among the recipients, Chairman Makoto Nakao's book, titled "Growth strategy by overseas expansion and quality management - 100 years trajectory of global middle-sized enterprise," has received the "Nikkei QC Literature Prize".